Showing results (91-100 of 286) with videos related to
Sort By:
Pageof 29
Gastroenterology|December 8, 2016
A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset DiabetesBen Boursi, Brian Finkelman, Bruce J Giantonio, et al.Stem Cell Research & Therapy|February 26, 2014
Modeling inflammation and oxidative stress in gastrointestinal disease development using novel organotypic culture systemsKira G Hartman, James D Bortner, Gary W Falk, et al.Molecular and Cellular Biology|July 1, 2005
Activation of a nuclear Cdc2-related kinase within a mitogen-activated protein kinase-like TDY motif by autophosphorylation and cyclin-dependent protein kinase-activating kinaseZheng Fu, Melanie J Schroeder, Jeffrey Shabanowitz, et al.The Journal of Clinical Investigation|September 18, 2002
A mouse model of human oral-esophageal cancerOliver G Opitz, Hideki Harada, Yasir Suliman, et al.Cancer Biology & Therapy|March 25, 2015
FBXO4 loss facilitates carcinogen induced papilloma development in miceZhaorui Lian, Eric K Lee, Adam J Bass, et al.Molecular Cancer Therapeutics|September 16, 2008
Bortezomib induces apoptosis in esophageal squamous cell carcinoma cells through activation of the p38 mitogen-activated protein kinase pathwayMercedes Lioni, Kazuhiro Noma, Andrew Snyder, et al.The Journal of Clinical Investigation|June 3, 2009
The diabetes gene Pdx1 regulates the transcriptional network of pancreatic endocrine progenitor cells in miceJennifer M Oliver-Krasinski, Margaret T Kasner, Juxiang Yang, et al.Molecular Imaging|May 15, 2014
Fluorescent nanoparticle imaging allows noninvasive evaluation of immune cell modulation in esophageal dysplasiaPeiman Habibollahi, Todd Waldron, Pedram Heidari, et al.Cancer Cell|July 5, 2008
Mutations in Fbx4 inhibit dimerization of the SCF(Fbx4) ligase and contribute to cyclin D1 overexpression in human cancerOlena Barbash, Petia Zamfirova, Douglas I Lin, et al.Cancer Research|November 3, 2006
Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous RasSeok-Hyun Kim, Hiroshi Nakagawa, Arunasalam Navaraj, et al.Pageof 29